Navigation Links
Rubbermaid Commercial Products Debuts Industry's First Disposable Microfiber

WINCHESTER, Va., Sept. 23, 2013 /PRNewswire/ -- Rubbermaid Commercial Products (RCP), the leader in innovative, solutions-based commercial products, today announced the availability of the Rubbermaid HYGEN™ Disposable Microfiber System for efficient cleaning and infection prevention in the healthcare environment.

The Rubbermaid HYGEN Disposable Microfiber System is designed and proven by third-party testing to remove 99.9 percent of microbes, which includes C. diff, a bacteria that can cause potentially life-threatening infections. The Rubbermaid HYGEN Disposable Microfiber System also features built-in scrubbers that enable complete dirt removal without smearing.

"With healthcare-associated infections resulting in the loss of tens of thousands of lives and costing billions, microbe removal is crucial," said Alison Kapp, marketing manager, hard surface commercial cleaning for Rubbermaid Commercial Products. "What people don't realize is that even if microbes are killed by chemicals, they remain on surfaces and become food for live pathogens. We're excited to debut a solution that changes the cleaning game by removing these microbes to facilitate infection prevention and ensure patient safety."

The first product to deliver the cleaning power and efficacy of microfiber at a disposable price point, the Rubbermaid HYGEN Disposable Microfiber System enables cleaning staff to do more with less to improve productivity. The highly absorbent microfiber yarn used provides 50 percent more surface area coverage per cloth compared to leading competitors. The disposable microfiber mop can be used wet or dry and is compatible with Rubbermaid Pulse™ or Rubbermaid HYGEN Charging Bucket.

Application areas include occupied and discharge patient rooms; emergency and isolation rooms; intensive care units; nurses' stations, X-ray stations and MRI stations; and other public areas.

For more information and to request a free sample, visit

About Rubbermaid Commercial Products   
Rubbermaid Commercial Products (RCP), headquartered in Winchester, Va., is a manufacturer of innovative, solution-based products for commercial and institutional markets worldwide. Since 1968, RCP has pioneered technologies and system solutions in the categories of food services, sanitary maintenance, waste handling, material transport, away-from-home washroom and safety products. RCP, an ISO 9001:2000 manufacturer, is part of Newell Rubbermaid's global portfolio of leading brands and continues to develop innovative products. Visit

SOURCE Rubbermaid Commercial Products
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
2. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
3. Acella Pharmaceuticals Announces a New Addition to the Commercial Team
4. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
5. New Executive Vice President Commercial Appointed
6. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
7. Pharmaceutical Commercial Leaders Seek Global Benchmarks for More Informed Decision-Making
8. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
9. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
10. Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies
11. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
Post Your Comments:
(Date:11/25/2015)... Calif. , Nov. 25, 2015  Amgen (NASDAQ: ... Biologics License Application (BLA) with the United ... for ABP 501, a biosimilar candidate to Humira ® ... adalimumab biosimilar application submitted to the FDA and represents ... Sean E. Harper , M.D., executive vice ...
(Date:11/25/2015)... WOODBURY, N.Y. , Nov. 25, 2015  Linden ... access and optimizing treatment outcomes for patients suffering from ... its request for a Temporary Restraining Order (TRO) enjoining ... between the two companies. --> ... aggressively pursuing all of its legal options. ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... November 28, 2015 , ... ... teleradiology services, has added Chris Hafey and Claude Hooton to its board of ... Society of North America (RSNA) 2015 Annual Meeting and continues to strategically transform ...
(Date:11/28/2015)... ... November 28, 2015 , ... Beginning November 30th at 6:00 a.m. EST until 11:59 ... savings. , With possible savings of up to 20% off orders $80 or more to ... the website every few hours. , As a competitive e-commerce website for skin care and ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... American Dental Association meeting in Washington D.C. revolved around the fact that proper dental ... health. The talk stressed the link between periodontal disease (more commonly referred to as ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When ... said an inventor from Hillside, N.J. "Many people catch diseases simply from sitting ... individuals will always be protected from germs." , He developed the patent-pending QUDRATECS ...
Breaking Medicine News(10 mins):